MATINAS BIOPHARMA HOLDINGS, INC. Restricted Cash, Current
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Restricted Cash, Current of $50.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-08-13
- 2026-06-30: Restricted Cash, Current $50.00K.
- 2026-03-31: Restricted Cash, Current $50.00K.
- 2025-12-31: Restricted Cash, Current $50.00K.
- 2025-09-30: Restricted Cash, Current $50.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-30 | $50.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $50.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $50.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $50.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $50.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $50.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $50.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $50.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $50.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $50.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $50.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | $50.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $50.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $50.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $50.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $50.00K 10-Q · filed 2022-11-02 |
| 2022-06-30 | $50.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $50.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $50.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | $50.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $136.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $136.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $136.00K 10-K/A · filed 2022-03-11 |
| 2020-09-30 | $186.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $200.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $150.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $250.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $200.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $100.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $100.00K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $100.00K 10-K · filed 2020-03-09 |
| 2018-09-30 | $200.00K 10-Q · filed 2018-11-09 |
| 2017-12-31 | $155.43K 10-K · filed 2019-04-01 |
| 2017-09-30 | $155.40K 10-Q · filed 2017-11-14 |
| 2016-12-31 | $155.61K 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |